Suchergebnisse - "Nishino, Hiroto"

PubPharm (9)

1

Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft

enthalten in: In vivo (Athens, Greece) | 2022

von Turner, M. | Hollandsworth, H. | Nishino, H. | +9

2

A Patient-Derived Orthotopic Xenograft Model of Gastroesophageal-Junction Adenocarcinoma Translated to the Clinic by Tumor-Targeting Fluorescent Antibodies to Carcinoembryonic-Antigen-Related Cell-Adhesion Molecules

enthalten in: In vivo (Athens, Greece) | 2021

von Turner, M. | Amirfakhri, S. | Nishino, H. | +6

3

Ligation Method to Specifically Label a Liver Segment With Indocyanine Green in an Orthotopic Nude-Mouse Liver-Metastasis Model

enthalten in: In vivo (Athens, Greece) | 2020

von Nishino, H. | Hollandsworth, H. | Tashiro, Y. | +6

4

Sutureless Surgical Orthotopic Implantation Technique of Primary and Metastatic Cancer in the Liver of Mouse Models

enthalten in: In vivo (Athens, Greece) | 2020

von Nishino, H. | Hollandsworth, H. | Sugisawa, N. | +10

5

Response of Triple-negative Breast Cancer Liver Metastasis to Oral Recombinant Methioninase in a Patient-derived Orthotopic Xenograft (PDOX) Model

enthalten in: In vivo (Athens, Greece) | 2020

von Lim, H. | Yamamoto, J. | Han, Q. | +9

6

Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model

enthalten in: Anticancer research | 2020

von Yamamoto, J. | Murata, T. | Sugisawa, N. | +16

7

A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model

enthalten in: Anticancer research | 2020

von Lim, H. | Yamamoto, J. | Inubushi, S. | +13

8

A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib

enthalten in: Anticancer research | 2020

von Yamamoto, J. | Murata, T. | Tashiro, Y. | +17

9

PPARγ Agonist Pioglitazone in Combination With Cisplatinum Arrests a Chemotherapy-resistant Osteosarcoma PDOX Model

enthalten in: Cancer genomics & proteomics | 2020

von Higuchi, T. | Yamamoto, J. | Sugisawa, N. | +11

1
[1]